Xenon (XENE) Q3 2026 Earnings Call Transcript
Xenon's NDA filing and pain drug data point to a busy stretch ahead.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Nerdy (NRDY) Q3 2026 Earnings Call Transcript
Self-service acquisition and AI-driven cuts reshaped the quarter.
Trevi Therapeutics (TRVI) Q3 2026 Earnings Call Transcript
Cash runway now reaches 2030 as key trial timelines come into focus.
Global equities to rely on earnings growth as investor risk appetite weakens: Goldman Sachs
Goldman Sachs maintained an overweight stance on bonds, particularly longer-duration government securities.
Malaysia's October palm oil stocks hit new peak as output surges
KUALA LUMPUR: Malaysia’s palm oil stocks reached a new peak in October, after another record month of output more than offset the rebound in exports, data from the industry regulator showed on…
2027 interest rate risks, falling loan approvals cloud housing outlook: JLL Malaysia
KUALA LUMPUR: Malaysia's residential property market could face mounting pressure in 2027 as declining housing loan approval rates, tighter lending practices and the prospect of higher borrowing costs…
FTSE 100 Live: Stocks to climb; Trump says Iran war ‘effectively over’
Welcome back to City AM‘s FTSE 100 live blog. It’s Tuesday morning and stocks are set to climb higher as traders continue the week’s positive start.